When it comes to weight loss, we've all been told that eating a healthy, balanced diet holds the key to success. But for many ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...